Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxwell M Krem

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
American Journal of Hematology|January 3, 2023
Targeting MCL-1 and BCL-2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non-Hodgkin lymphoma: Results from preclinical models and a Phase Ib studyElisabeth A Lasater, Dhara N Amin, Rajat Bannerji, et al.
JAMA Oncology|May 6, 2021
Outcomes Associated With Thiotepa-Based Conditioning in Patients With Primary Central Nervous System Lymphoma After Autologous Hematopoietic Cell TransplantMichael Scordo, Trent P Wang, Kwang W Ahn, et al.
Blood Neoplasia|March 23, 2026
Impact of age on outcomes after CD19 CAR T-cell therapy for large B-cell lymphomasAbu-Sayeef Mirza, Chitra Hosing, Francine Foss, et al.
Haematologica|February 13, 2023
Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosisGuru Subramanian Guru Murthy, Soyoung Kim, Noel Estrada-Merly, et al.
Transplantation and Cellular Therapy|April 25, 2021
Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United StatesNeel S Bhatt, Ruta Brazauskas, Rachel B Salit, et al.
Transplantation and Cellular Therapy|January 26, 2022
Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant ResearchHemant S Murthy, Kwang Woo Ahn, Noel Estrada-Merly, et al.
Bone Marrow Transplantation|September 29, 2021
An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysisAntonio M Jimenez Jimenez, Marcos De Lima, Krishna V Komanduri, et al.
Blood Advances|June 25, 2024
Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR studyTania Jain, Noel Estrada-Merly, M Queralt Salas, et al.
Blood Advances|October 4, 2023
Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysisHemant S Murthy, Mei-Jie Zhang, Karen Chen, et al.
Blood Advances|September 21, 2021
Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemiaMatthew J Wieduwilt, Leland Metheny, Mei-Jie Zhang, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
American Journal of Hematology|January 3, 2023
Targeting MCL-1 and BCL-2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non-Hodgkin lymphoma: Results from preclinical models and a Phase Ib studyElisabeth A Lasater, Dhara N Amin, Rajat Bannerji, et al.
JAMA Oncology|May 6, 2021
Outcomes Associated With Thiotepa-Based Conditioning in Patients With Primary Central Nervous System Lymphoma After Autologous Hematopoietic Cell TransplantMichael Scordo, Trent P Wang, Kwang W Ahn, et al.
Blood Neoplasia|March 23, 2026
Impact of age on outcomes after CD19 CAR T-cell therapy for large B-cell lymphomasAbu-Sayeef Mirza, Chitra Hosing, Francine Foss, et al.
Haematologica|February 13, 2023
Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosisGuru Subramanian Guru Murthy, Soyoung Kim, Noel Estrada-Merly, et al.
Transplantation and Cellular Therapy|April 25, 2021
Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United StatesNeel S Bhatt, Ruta Brazauskas, Rachel B Salit, et al.
Transplantation and Cellular Therapy|January 26, 2022
Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant ResearchHemant S Murthy, Kwang Woo Ahn, Noel Estrada-Merly, et al.
Bone Marrow Transplantation|September 29, 2021
An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysisAntonio M Jimenez Jimenez, Marcos De Lima, Krishna V Komanduri, et al.
Blood Advances|June 25, 2024
Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR studyTania Jain, Noel Estrada-Merly, M Queralt Salas, et al.
Blood Advances|October 4, 2023
Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysisHemant S Murthy, Mei-Jie Zhang, Karen Chen, et al.
Blood Advances|September 21, 2021
Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemiaMatthew J Wieduwilt, Leland Metheny, Mei-Jie Zhang, et al.
Pageof 4